Late cytomegalovirus disease following liver transplantation
- 1 December 2003
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 16 (12), 861-865
- https://doi.org/10.1111/j.1432-2277.2003.tb00255.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Allograft Rejection Predicts the Occurrence of Late‐Onset Cytomegalovirus (CMV) Disease among CMV‐Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral GanciclovirThe Journal of Infectious Diseases, 2001
- Prevention of Cytomegalovirus Disease in Recipients of Solid-Organ TransplantsClinical Infectious Diseases, 2001
- The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantationNephrology Dialysis Transplantation, 2000
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Infection in solid organ transplantationTransplant Infectious Disease, 1999
- Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipientsThe Lancet, 1997
- Exposure to Cytomegalovirus from the Donated Organ Is a Risk Factor for Bacteremia in Orthotopic Liver Transplant RecipientsClinical Infectious Diseases, 1996
- Cytomegalovirus Infection Following Liver Transplantation: Review of the LiteratureClinical Infectious Diseases, 1996
- OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver TransplantationThe Journal of Infectious Diseases, 1995
- The indirect effects of cytomegalovirus infection on the outcome of organ transplantationPublished by American Medical Association (AMA) ,1989